Skip to Main Content

Paper Details

BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma.
Cancers (Basel)
15
2021
Arg, B cell malignancies, BTK, CAR-T, CD8+, CD8+ T cell, Ibrutinib, Ido, MDSC, MDSCs, NB, NB tumors, NO, Neuroblastoma, PDL1, Tgf, anti-PDL1, cancers, granulocytic and monocytic murine MDSCs, ibrutinib, immune cells, mRNA, mice, murine, murine MDSCs, myeloid lineage, patients, tumor, tumors
Author NameAffiliation
Pablo TamayoUniversity of California
Pablo TamayoUniversity of California
Shweta JoshiMoores Cancer Center, University of California
  • 1 - 3

Datasets

Release 1.2